FDA grants full approval for Roche/AbbVie’s Venclexta in AML combination therapiesCombination therapies involving Roche and AbbVie’s cancer drug Venclexta have been formally approved by the FDA in acute Share XFDA grants full approval for Roche/AbbVie’s Venclexta in AML combination therapieshttps://pharmaphorum.com/news/fda-grants-full-approval-for-roche-abbvies-venclexta-in-aml-combination-therapies/
COVID-19 tests prop up Roche as US biosimilars bite in Q3Roche’s pharmaceutical revenues have been hit by falling sales in its pharma division in Q3 but a spike Share XCOVID-19 tests prop up Roche as US biosimilars bite in Q3https://pharmaphorum.com/news/us-biosimilars-bite-into-roches-pharma-revenues/
Harmony’s sleep disorder drug Wakix gets US label extensionHarmony Biosciences has scored an expanded use for its Wakix narcolepsy drug to include cataplexy – a symptom Share XHarmony’s sleep disorder drug Wakix gets US label extensionhttps://pharmaphorum.com/news/harmonys-narcolepsy-drug-gets-extended-cataplexy/
J&J settles 1,000 talc lawsuits for $100m+; reportJohnson & Johnson has agreed to pay more than $100 million to settle over 1,000 lawsuits that allege Share XJ&J settles 1,000 talc lawsuits for $100m+; reporthttps://pharmaphorum.com/news/j-report/
Field Trip becomes latest psychedelic firm to go publicPsychedelic therapy company Field Trip Psychedelics has announced that it will soon join the growing list of psychedelic Share XField Trip becomes latest psychedelic firm to go publichttps://pharmaphorum.com/news/field-trip-becomes-latest-psychedelic-firm-to-go-public/
Gilead’s rheumatoid arthritis pill approved in JapanGilead has scored a major approval for its troubled rheumatoid arthritis pill filgotinib, after regulators in Japan granted Share XGilead’s rheumatoid arthritis pill approved in Japanhttps://pharmaphorum.com/news/gileads-rheumatoid-arthritis-pill-approved-in-japan/
Gilead pays $97m to resolve US illegal kickback claimsGilead has paid $97 million to resolve claims by US authorities that it acted illegally by using a Share XGilead pays $97m to resolve US illegal kickback claimshttps://pharmaphorum.com/news/gilead-pays-97m-to-resolve-us-illegal-kickback-claims/
Drama as J&J partner Legend’s CEO is detained after Chinese customs raidsJust a month after taking up the CEO role at Legend Biotech, Frank Zhang has been forced to Share XDrama as J&J partner Legend’s CEO is detained after Chinese customs raidshttps://pharmaphorum.com/news/drama-as-jj-partner-legends-ceo-is-detained-after-chinese-customs-raids/
ARK and Syneos Health Communications top agency charts at 2020 PM Society Digital AwardsThe winners of the 2020 PM Society Digital Awards have been announced, with ARK and Syneos Health topping Share XARK and Syneos Health Communications top agency charts at 2020 PM Society Digital Awardshttps://pharmaphorum.com/sales-marketing/ark-and-syneos-health-communications-top-agency-charts-at-2020-pm-society-digital-awards/
